| Outgoing Relation(s) |
| EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) is a EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor (CHEBI:76841) |
| Incoming Relation(s) |
| (RS)-mallotophilippen E (CHEBI:66659) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| (−)-demethoxylpinoresinol (CHEBI:65738) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| (2R*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E)-7-nonadien-6-onyl]furo[3,2-c]coumarin (CHEBI:65928) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| (2S*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E),7-nonadien-6-onyl]-furo[3,2-c]coumarin (CHEBI:65929) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| (2S*,3R*)-2,3-dihydro-7-methoxy-2,3-dimethyl-2-[4-methyl-5-(4-methyl-2-furyl)-3(E)-pentenyl]-furo[3,2-c]coumarin (CHEBI:65930) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| N-[3-(aminomethyl)benzyl]acetamidine (CHEBI:90721) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| N6-acetimidoyl-L-lysine dihydrochloride (CHEBI:63964) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| Nγ-nitro-L-arginine methyl ester (CHEBI:7549) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| Nγ-nitro-L-arginine methyl ester hydrochloride (CHEBI:131182) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| Nω,N'ω-dimethyl-L-arginine (CHEBI:25682) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| Nω,Nω-dimethyl-L-arginine (CHEBI:17929) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| S-methyl-L-thiocitrulline (CHEBI:90712) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| L-citrulline (CHEBI:16349) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| L-glutamine (CHEBI:18050) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone (CHEBI:66033) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 1-O-acetyl-4R,6S-britannilactone (CHEBI:65365) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 3-O-methyl-isosecotanapartholide (CHEBI:66090) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 4-hydroxycinnamaldehyde (CHEBI:28353) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 5-hydroxyzerumbone (CHEBI:66050) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 6-propyl-2-thiouracil (CHEBI:8502) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| 7-nitroindazole (CHEBI:40287) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| ainsliadimer A (CHEBI:65376) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| aminoguanidine (CHEBI:40618) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| bis(7)-tacrine (CHEBI:138435) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| D-NAME hydrochloride (CHEBI:233136) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| dihydroxanthohumol (CHEBI:66332) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| formamidine (CHEBI:38477) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin A (CHEBI:65921) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin B (CHEBI:65922) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin C (CHEBI:65923) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin D (CHEBI:65924) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin E (CHEBI:65925) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin F (CHEBI:65926) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanefuromarin G (CHEBI:65927) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanemarin A (CHEBI:65919) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| fukanemarin B (CHEBI:65920) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| futokadsurin A (CHEBI:65936) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| futokadsurin B (CHEBI:65937) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| futokadsurin C (CHEBI:65938) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| indicanone (CHEBI:66072) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| isosecotanapartholide (CHEBI:66089) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| mallotophilippen A (CHEBI:66655) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| mallotophilippen B (CHEBI:66656) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| mallotophilippen C (CHEBI:66657) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| mallotophilippen D (CHEBI:66658) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| methyl propenyl ketone (CHEBI:89540) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| methylguanidine (CHEBI:16628) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| myricitrin (CHEBI:70082) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| nitroflurbiprofen (CHEBI:77428) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| oroxylin A (CHEBI:61668) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| oroxylin A(1−) (CHEBI:77939) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| oxygenated xanthohumol (CHEBI:66333) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| paraminabeolide A (CHEBI:67560) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| paraminabeolide B (CHEBI:67561) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| paraminabeolide C (CHEBI:67562) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| paraminabeolide D (CHEBI:67563) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| phoyunbene A (CHEBI:66753) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| phoyunbene B (CHEBI:66754) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| phoyunbene C (CHEBI:66755) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| phoyunbene D (CHEBI:66756) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| spermidine trihydrochloride (CHEBI:233088) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| thienodolin (CHEBI:9543) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| triptoquinone A (CHEBI:132352) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| xanthohumol B (CHEBI:66334) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| xanthohumol D (CHEBI:66335) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| zaluzanin C (CHEBI:10103) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
| zerumboneoxide (CHEBI:66502) has role EC 1.14.13.39 (nitric oxide synthase) inhibitor (CHEBI:61908) |
